The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages

References

• Vercellini P, Vigano P, Frattaruolo MP, Somigliana E. Proliferation of gynaecological scientific societies and their financial transparency: an Italian survey. BMJ Open. 2016;6(1):e008370. PMID:26769777
   PubMed Web of Science ®Google Scholar
• Italian Ministry of Health. National Immnunization Prevention Plan 2017–2019. IPublished on the italian official gazette, Februrary 18th 2017. Available at http://www.gazzettaufficiale.it/eli/id/2017/02/18/17A01195/sg [accessed: 18/03/2017].
   Google Scholar
• Council of The European Union. Council conclusions on vaccinations as an effective tool in public health, 2014. http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/145973.pdf [Accessed 26.12.2014].
   Google Scholar
• The World Health Organization. Regional office for europe. European region vaccine action plan 2015–2020. 2014. http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/2014/european-vaccine-action-plan-20152020-2014 [Accessed 31.12.2014].
   Google Scholar
• Odone A, Signorelli C. When vaccine hesitancy makes headlines. Vaccine. 2017;35(9):1209-10. PMID:26657186
   PubMed Web of Science ®Google Scholar
• Odone A, Fara GM, Giammaco G, Blangiardi F, Signorelli C. The future of immunization policies in Italy and in the European Union: The Declaration of Erice. Hum Vaccin Immunother. 2015;11(5):1268-71. PMID:25806425
   PubMed Web of Science ®Google Scholar
• Signorelli C, Odone A. Advocacy communication, vaccines and the role of scientific societies. Ann Ig. 2015;27(5):737-47. PMID:26661915
   PubMedGoogle Scholar
• Ferrè F, de Belvis AG, Valerio L, Longhi S, Lazzari A, Fattore G, Ricciardi W, Maresso A. Italy: Health system review. Health Syst Transit. 2014;16(4):1-168. Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/263253/HiT-Italy.pdf?ua = 1. PMID:25471543
   PubMedGoogle Scholar
• Ricciardi GW, Toumi M, Weil-Olivier C, Ruitenberg EJ, Danko D, Duru G, Picazo J, Zöllner Y, Poland G, Drummond M. Comparison of NITAG policies and working processes in selected developed countries. Vaccine. 2015;33(1):3-11. PMID:25258100
   PubMed Web of Science ®Google Scholar
• Bonanni P, Azzari C, Castiglia P, Chiamenti G, Conforti G, Conversano M, Corsello G, Ferrera G, Ferro A, Icardi G, et al. [The 2014 Lifetime Immunization Schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Health. Italian Society of Pediatrics. Italian Federation of Pediatric Physicians. Italian Federation of General Medical Physicians]. Epidemiol Prev. 2014;38(6 Suppl 2):131-46. PMID:25759359
   PubMedGoogle Scholar
• Bonanni P, Ferro A, Guerra R, Iannazzo S, Odone A, Pompa MG, Rizzuto E, Signorelli C. Vaccine coverage in Italy and assessment of the 2012–2014 national immunization prevention plan. Epidemiol Prev. 2015;39(4 Suppl 1):146-58. PMID:26499433
   PubMed Web of Science ®Google Scholar
• Signorelli C, Odone A, Bonanni P, Russo F. New Italian immunisation plan is built on scientific evidence: Carlo Signorelli and colleagues reply to news article by Michael Day. BMJ. 2015;351:h6775. PMID:26667823
   PubMed Web of Science ®Google Scholar
• Signorelli C. Vaccines: building on scientific excellence and dispelling false myths. Epidemiol Prev. 2015;39(3):198-201. PMID:26522283
   PubMed Web of Science ®Google Scholar
• Signorelli C, Guerra R, Siliquini R, Ricciardi W. Italy's response to vaccine hesitancy: An innovative and cost effective National Immunization Plan based on scientific evidence. Vaccine. 2017;35(33):4057-9. doi:10.1016/j.vaccine.2017.06.011.
   PubMed Web of Science ®Google Scholar
• Day M. Italian expert questions need for expanded vaccination schedule. BMJ. 2015;351:h6181. https://doi.org/10.1136/bmj.h6181 PMID:26573246
   PubMed Web of Science ®Google Scholar
• Biasio LR, Corsello G, Costantino C, Fara GM, Giammanco G, Signorelli C, Vecchio D, Vitale F. Communication about vaccination: A shared responsibility. Hum Vaccin Immunother. 2016;12(11):2984-7. https://doi.org/10.1080/21645515.2016.1198456 PMID:27458874
   PubMed Web of Science ®Google Scholar
• Bonanni P, Signorelli C. Anti-rotavirus: no evidence to discontinue the universal vaccination policy. Ig San Pub. 2015;LXXI.5.2015:559-567.
   Google Scholar
• Signorelli C, Chiesa V, Odone A. Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectives. J Prev Med Hyg. 2015;56(3):E125-32. PMID:26788733
   PubMedGoogle Scholar
• Crosignani P, De Stefani A, Fara GM, Isidori AM, Lenzi A, Liverani CA, Lombardi A, Mennini FS, Palu' G, Pecorelli S, et al. Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health. 2013;13:642. https://doi.org/10.1186/1471-2458-13-642 PMID:23845195
   PubMed Web of Science ®Google Scholar
• Audisio RA, Icardi G, Isidori AM, Liverani CA, Lombardi A, Mariani L, Mennini FS, Mitchell DA, Peracino A, Pecorelli S, et al. Public health value of universal HPV vaccination. Crit Rev Oncol Hematol. 2016;97:157-67. PMID:26346895
   PubMed Web of Science ®Google Scholar
• Blasi F, Aliberti S, Bonanni P, Mantero M, Odone A, Signorelli C. [Pneumococcal vaccination in adults: recommendations from the Italian Society of Respiratory Medicine (SIMeR) and the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI)]. Epidemiol Prev. 2014;38(6 Suppl 2):147-51. PMID:25759360
   PubMedGoogle Scholar
• Advisory Committee on Immunization Practices-ACIP. Available at http://www.cdc.gov/vaccines/acip/index.html [accessed: 17/03/2017].
   Google Scholar
• European Center for Disease Prevention and Control.Vaccine Schedule. Available at: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx. [accessed: 17/03/2017].
   Google Scholar
• Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Krüger H, Wahn U, Schaberg T, Schwehm M, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014;14:40. https://doi.org/10.1186/1471-2334-14-40 PMID:24450996
   PubMed Web of Science ®Google Scholar
• Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: An evidence synthesis and modelling study. PLoS Med. 2013;10(10):e1001527. https://doi.org/10.1371/journal.pmed.1001527 PMID:24115913
   PubMed Web of Science ®Google Scholar
• Department of Health. The flu immunisation programme 2013/14 – extension to children, 2013. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/225360/Children_s_flu_letter_2013.pdf [accessed: 07.04.2017].
   Google Scholar
• Yen C, Healy K, Tate JE, Parashar UD, Bines J, Neuzil K, Santosham M, Steele AD. Rotavirus vaccination and intussusception – Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries. Hum Vaccin Immunother. 2016;12(10):2580-9. https://doi.org/10.1080/21645515.2016.1197452 PMID:27322835
   PubMed Web of Science ®Google Scholar
• Vesikari T, Van Damme P, Giaquinto C, Dagan R, Guarino A, Szajewska H, Usonis V. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: Update 2014. Pediatr Infect Dis J. 2015;34(6):635-43. https://doi.org/10.1097/INF.0000000000000683 PMID:25860532
   PubMed Web of Science ®Google Scholar
• Vetter V, Baxter R, Denizer G, Safadi MA, Silfverdal SA, Vyse A, Borrow R. Routinely vaccinating adolescents against meningococcus: Targeting transmission & disease. Expert Rev Vaccines. 2016;15(5):641-58. https://doi.org/10.1586/14760584.2016.1130628 PMID:26651380
   PubMed Web of Science ®Google Scholar
• Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolesc Health: Official publication of the Society for Adolescent Medicine. 2016;59(2 Suppl):S3-s11. https://doi.org/10.1016/j.jadohealth.2016.04.012
   PubMed Web of Science ®Google Scholar
• AAP Committee on Infectious Diseases. Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older. Pediatrics. 2016;138(3):e20161890.
   Web of Science ®Google Scholar
• Nunes MC, Aqil AR, Omer SB, Madhi SA. The effects of influenza vaccination during pregnancy on birth outcomes: A systematic review and meta-analysis. Am J Perinatol. 2016;33(11):1104-14. https://doi.org/10.1055/s-0036-1586101 PMID:27603545
   PubMed Web of Science ®Google Scholar
• Bratton KN, Wardle MT, Orenstein WA, Omer SB. Maternal influenza immunization and birth outcomes of stillbirth and spontaneous abortion: A systematic review and meta-analysis. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America. 2015;60(5):e11-9. https://doi.org/10.1093/cid/ciu915 PMID:25409473
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359(15):1555-64. https://doi.org/10.1056/NEJMoa0708630 PMID:18799552
   PubMed Web of Science ®Google Scholar
• Forsyth K, Plotkin S, Tan T, Wirsing von Konig CH. Strategies to decrease pertussis transmission to infants. Pediatrics. 2015;135(6):e1475-82. https://doi.org/10.1542/peds.2014-3925 PMID:25963002
   PubMed Web of Science ®Google Scholar
• Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP. Cost-effectiveness of pertussis vaccination during pregnancy in the United States. Am J Epidemiol. 2016;183(12):1159-70. https://doi.org/10.1093/aje/kwv347 PMID:27188951
   PubMed Web of Science ®Google Scholar
• Regan AK. The safety of maternal immunization. Hum Vaccin Immunother. 2016;12(12):3132-6. https://doi.org/10.1080/21645515.2016.1222341 PMID:27541370
   PubMed Web of Science ®Google Scholar
• Ten great public health achievements–United States, 2001–2010{, 2011 #26}. MMWR Morb Mortal Wkly Rep. 2011;60(19):619-23. PMID:21597455
   PubMedGoogle Scholar
• Hinman AR, Orenstein WA, Schuchat A. Vaccine-preventable diseases, immunizations, and MMWR–1961-2011. MMWR Surveill Summ. 2011;60 Suppl 4:49-57.
   Google Scholar
• Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155-63. https://doi.org/10.1001/jama.298.18.2155 PMID:18000199
   PubMed Web of Science ®Google Scholar
• Blank PR, Schwenkglenks M, Sardos CS, Patris J, Szucs TD. Population access to new vaccines in European countries. Vaccine. 2013;31(27):2862-7. https://doi.org/10.1016/j.vaccine.2013.04.039 PMID:23632307
   PubMed Web of Science ®Google Scholar
• Signorelli C, Odone A, Bianco D, Di Vivo N, Bevere F. [Health expenditure for prevention in Italy (2006-2013): Descriptive analysis, regional trends and international comparisons]. Epidemiol Prev. 2016;40(5):374-80. PMID:27764919
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health & Human Services. A Review and Analysis of Economic Models of Prevention Benefits, 2013. https://aspe.hhs.gov/basic-report/review-and-analysis-economic-models-prevention-benefits [accessed 8.6.2017].
   Google Scholar
• Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes care. 2008;31(8):1686-96. https://doi.org/10.2337/dc08-9022 PMID:18663233
   PubMed Web of Science ®Google Scholar
• Sassi F, Cecchini M, Lauer J, Chisholm D. Improving Lifestyles, Tackling Obesity: The Health and Economic Impact of Prevention Strategies, OECD Health Working Papers, No. 48, OECD Publishing, Paris. 2009, DOI:10.1787/220087432153.
   Google Scholar